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Abstract
Background: Pigs (Sus scrofa) provide relevant biomedical models to dissect complex diseases due to their anatomical,
genetic, and physiological similarities with humans. Aberrant DNA methylation has been linked to many of these
diseases and is associated with gene expression; however, the functional similarities and differences between porcine
and human DNA methylation patterns are largely unknown.
Methods: DNA and RNA was isolated from eight tissue samples (fat, heart, kidney, liver, lung, lymph node, muscle, and
spleen) from the adult female Duroc utilized for the pig genome sequencing project. Reduced representation bisulfite
sequencing (RRBS) and RNA-seq were performed on an Illumina HiSeq2000. RRBS reads were aligned using BSseeker2,
and only sites with a minimum depth of 10 reads were used for methylation analysis. RNA-seq reads were aligned
using Tophat, and expression analysis was performed using Cufflinks. In addition, SNP calling was performed using
GATK for targeted control and whole genome sequencing reads for CpG site validation and allelic expression analysis,
respectively.
Results: Analysis on the influence of DNA variation in methylation calling revealed a reduced effectiveness of WGS
datasets in covering CpG rich regions, as well as the usefulness of a targeted control library for SNP detection. Analysis
of over 500,000 CpG sites demonstrated genome wide methylation patterns similar to those observed in humans,
including reduced methylation within CpG islands and at transcription start sites (TSS), X chromosome inactivation, and
anticorrelation of TSS CpG methylation with gene expression. In addition, a positive correlation between TSS CpG
density and expression, and a negative correlation between TSS TpG density and expression were demonstrated. Low
but non-random non-CpG methylation (<1%) was also detected in all non-neuronal somatic tissues, with differences in
tissue clustering observed based on CpG and non-CpG methylation patterns. Finally, allele specific expression analysis
revealed enrichment of genes involved in metabolic and regulatory processes.
Discussion: These results provide transcriptional and DNA methylation datasets for the biomedical community that are
directly relatable to current genomic resources. In addition, the correlation between TSS CpG density and expression
suggests increased mutation rates at CpG sites play a significant role in adaptive evolution by reducing CpG density at
TSS over time, resulting in higher methylation levels in these regions and more permanent changes to lower gene
expression. This is proposed to occur predominantly through deamination of 5-methylcytosine to thymidine, resulting
in the replacement of CpG with TpG sites in these regions, as indicated by the increased TSS TpG density observed in
non-expressed genes, resulting in a negative correlation between expression and TSS TpG density.
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Conclusions: This study provides baseline methylation and gene transcription profiles for a healthy adult pig, reports
similar patterns to those observed in humans, and supports future porcine studies related to human disease and
development. Additionally, the observed reduced CpG and increased TpG density at TSS of lowly expressed genes
suggests DNA methylation plays a significant role in adaptive evolution through more permanent changes to lower
gene expression.
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Background
Epigenetic mechanisms are stable and heritable modifi-
cations responsible for regulating gene transcription
without altering the DNA’s nucleotide sequence [1].
DNA methylation is a well understood epigenetic mechan-
ism [2]. Vertebrate DNA methylation involves the addition
of a methyl group to cytosine bases predominantly located
5’ adjacent to a guanine (CpG sites) throughout the gen-
ome. DNA methylation is associated with gene expression
and can be altered during responses to environmental fac-
tors [1], representing a link between gene expression and
the environment. This relationship provides a potentially
important role for DNA methylation in adaptive evolution,
as it is believed that regulatory changes in gene expression
play a particularly important role in the evolutionary
process [3, 4]. Additionally, the risk of developing diseases
such as diabetes, cardiovascular disease, and cancer has
been linked to environmental insults early in life and
throughout adulthood. Therefore it should be no surprise
that aberrant DNA methylation patterns have been
detected in the tissues of individuals suffering from many
human diseases including neurodegenerative disorders,
diabetes, and cardiovascular disease [5], as well as colorec-
tal [6], ovarian [7], prostate [8], lung [9], and breast
cancers [10]. Such studies highlight the importance of
methylation patterns and their potential use as biomarkers
for early detection, diagnosis and prognosis of complex,
chronic diseases.
Recently pigs have emerged as an essential relevant
biomedical model due to their anatomical, genetic and
physiological similarities with humans, as well as their
broad availability, short generation interval and large
litter sizes [11–13]. Pigs provide ideal animal models, as
porcine studies have been shown to be in general more
predictive of therapeutic treatments in humans than ro-
dents [11], and pigs are also less expensive and ethically
more acceptable than canines and non-human primates.
There is a vast amount of research on the genetic and
environmental interactions associated with complex poly-
genic physiological traits in pigs, making them relevant
models for obesity, female health, cardiovascular disease,
nutritional and communicable disease studies [13]. Add-
itionally, pigs represent excellent models for defining how
environmental signals such as food, smoking, alcohol, and
stress affect DNA methylation and contribute to chronic
diseases [14]. Currently there are a number of available
porcine models of human diseases which have been
associated with environmental insults and/or aberrant
DNA methylation patterns including cardiovascular dis-
ease [15–17], diabetes mellitus [18, 19], Alzheimer’s dis-
ease [20], obesity [21], necrotizing enterocolitis [22], and
cancer [23].
The recent completion of the swine reference genome
sequence [24] further enhances the ability of researchers
to perform porcine genotype-phenotype studies for many
human diseases, as well as opens the door for targeted ap-
proaches to produce tailor-made disease models [25]. Sev-
eral projects, including the Human ENCODE Project [26],
the Human Epigenome Project [27], the International Hu-
man Epigenome Consortium [28], and the NIH Roadmap
Epigenomics Program [29] have begun to profile epigen-
etic patterns in a variety of human cell types and condi-
tions, with the goal of producing maps of epigenetic
patterns and provide insights into their role in normal and
diseased states. While multiple methylation studies have
been performed in pigs to date, the majority of these are
limited to a small number of tissues and techniques with
either limited resolution or limited genomic coverage
[30–34]. As the connection between DNA methylation
and human disease continues to be developed, there is a
growing need to increase the availability of porcine epi-
genetic resources to fully utilize pigs as human disease
models, as well as understand the importance of epigen-
etic patterns in the process of evolution.
This study produced DNA methylome maps and gene
transcription profiles of eight tissues from the adult
Duroc female used for production of the swine reference
genome [24], reporting baseline porcine DNA methyla-
tion patterns similar to those observed in human somatic
cells, including a negative correlation between transcrip-
tion start site (TSS) CpG methylation and gene ex-
pression, and a positive correlation between gene body
CpG methylation and gene expression. These results
support the increased study of DNA methylation pat-
terns and their associations with the development, de-
tection, and potential treatment of relevant human
Schachtschneider et al. BMC Genomics  (2015) 16:743 Page 2 of 18
diseases in a porcine model. The additional positive
correlation observed between TSS CpG density and gene
expression, shown to result from the high rate of 5-
methylcytosine (CpG) deamination to thymidine (TpG),
provides evidence for a role of DNA methylation in




Tissue collection was conducted at slaughter according
to relevant national and international guidelines. Tissue
collection procedures were approved by The University
of Illinois Institutional Animal Care and Use Committee
(IACUC; Protocol numbers 99252 and 04006).
Sample Collection
Tissue samples (fat, heart, kidney, liver, lung, lymph
node, muscle, and spleen) were collected from the adult
female Duroc preferentially used for sequencing of the
swine reference genome (Duroc 12-4) [24]. The female
Duroc was maintained in a purebred breeding herd
monitored for clinical disease and management through
an active vaccination program, strategic medication and
medicated feeds. The vaccination program consisted of
vaccinations for Mycoplasma hyopneumoniae, Pasturella
multocida type D, Erysipelothrix rhusiopathiae, Parvo-
virus, leptospirosis, E. coli, and Clostridium perfringens
type C. All animals were inspected daily for health sta-
tus, and never displayed any symptoms of diseases nor
were treated. Although animals sequenced to generate
reference genomes tend to be inbred, and it is not un-
common for purebred livestock herds to have an in-
breeding coefficient of around 3% due to population
structure, the pedigree for this individual indicates an in-
breeding coefficient of 0%. Therefore, biases in the ana-
lysis due to regions of homozygosity are not expected.
The female Duroc was 3 years 4 months of age at the
time of euthanasia, at which point tissue samples were
harvested and stored at -80oC until processing.
DNA and RNA Isolation
Genomic DNA (gDNA) and total RNA were extracted
simultaneously from frozen tissue samples using the
AllPrep DNA/RNA Mini Kit (Qiagen, Valencia, CA,
USA) following the manufacturer’s protocol. The DNA
concentration was determined using a NanoDrop spec-
trophotometer and DNA quality was assessed by electro-
phoresis using a 1% agarose gel. RNA concentrations
were determined using a NanoDrop spectrophotometer
and analyzed by an Agilent 2100 Bioanalyzer using an
RNA Nano bioanalyzer chip to determine RNA integrity
as well as the presence/absence of gDNA by the Carver
High-Throughput DNA Sequencing and Genotyping
Unit (HTS lab, University of Illinois, Urbana, IL, USA).
Only RNA samples with a RNA integrity number greater
than 7 were used for sequencing.
RRBS and RNA-seq Library Preparation
High-quality gDNA (2 μg) was used for generation of
reduced representation bisulfite sequencing (RRBS) and
targeted control libraries by the HTS lab (University of
Illinois, Urbana, IL, USA) following standard protocols.
Briefly, gDNA was restriction digested using the methyl-
insensitive restriction enzyme Mspl, which cuts the
DNA at CCGG sites. The fragments were blunt-ended
and phosphorylated, and a single A nucleotide was
added to the 3' ends of the fragments in preparation for
ligation to a methylated adapter with a single-base T
overhang. The ligation products were purified and size-
selected (30 - 160 bp) using agarose gel electrophoresis.
Size-selected DNA was bisulfite-treated with the Epi-
Tech Bisulfite Kit (Qiagen, Valencia, CA, USA) and
column-purified. The treated DNA was PCR-amplified
to enrich for fragments with adapters on both ends. The
final libraries were quantified using Qubit (Life Tech-
nologies, Carlsbad, CA, USA) and the average size was
determined on an Agilent bioanalyzer DNA7500 DNA
chip (Agilent Technologies, Wilmington, DE, USA) and
diluted to 10 nM. The 10 nM dilution was further quan-
titated by qPCR on an ABI 1900 to ensure high accuracy
quantification for consistent pooling of barcoded librar-
ies and maximization of the number of clusters in the
Illumina flowcell. Targeted control libraries were pro-
duced in the same manner as RRBS libraries for each tis-
sue type, with the exception of the bisulfite treatment
step, in order to validate CpG sites.
High-quality RNA (1 μg) was used to generate TruSeq
Stranded RNA-seq libraries (TruSeq Stranded RNA
Sample Preparation Kit, Illumina, San Diego, CA, USA)
by the HTS lab (University of Illinois, Urbana, IL, USA)
following standard protocols. Briefly, messenger RNA
was isolated from the high quality DNAse treated total
RNA and first-strand synthesis performed with a ran-
dom hexamer and SuperScript II (Life Technologies,
Carlsbad, CA, USA). Second-strand synthesis was per-
formed using dUTP instead of dTTP. Double stranded
cDNA was blunt-ended, 3’-end A-tailed and ligated to
indexed adaptors. The adaptor–ligated double-stranded
cDNA was amplified by PCR for 10 cycles with the Kapa
HiFi polymerase (Kapa Biosystems, Woburn, MA, USA)
to reduce the likeliness of multiple identical reads due to
preferential amplification. The final libraries were quan-
tified prior to cluster generation as described above.
Illumina Sequencing
RRBS and RNA-seq Illumina sequencing was performed
on libraries multiplexed and loaded onto 8-lane flowcells
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for cluster formation and sequenced on an Illumina
HiSeq2000. The libraries were sequenced to a total read
length of 100 bp from one end (RRBS and targeted
control libraries, single-end sequencing) or both ends
(RNA-seq, paired-end sequencing) of the molecules. The
run generated .bcl files which were converted into
demultiplexed compressed fastq files using Casava 1.8.2
(Illumina, San Diego, CA, USA).
RRBS Data Analysis
An average of 50.3 million raw reads were produced for
each sample, ranging from 36 to 72.3 million (Additional
file 1: Table S1). The average bisulfite conversion rate
was 94.27 %, ranging between 93.48 % and 94.90 %. Raw
reads were trimmed for adapter contamination, mini-
mum quality score (20), experimentally introduced cyto-
sines, and minimum length (20bp) using Trim Galore
v.0.3.3 [35]. An in silico converted reduced representa-
tion swine genome was produced using the BS-seeker2
v.2.0.5 [36] bs_seeker2-build.py script with fragment
lengths between 20 and 180 bp (-r –l 20 –u 180).
Trimmed reads were aligned to the in silico converted
reduced representation swine genome with BS-seeker2
v.2.0.5 using Bowtie2 v.2.1.0 [37] in local alignment
mode, with a seed length of 20, a maximum of 1 mis-
match allowed in the seed alignment, and allowing no
more than 2 mismatches/read. Methylation level (de-
fined as the ratio of methylated/total reads at a given
site) was determined using the bs_seeker2-call_methyla-
tion.py script using only uniquely aligned reads. CpG
sites from each strand were combined, and all analyses
were performed using sites covered by a minimum of 10
reads in all samples to avoid biases caused by varying
sequencing depth.
All statistics were performed by importing the data into
R v.3.1.2 [38]. Cluster analysis was performed using
pvclust v.1.3.2 using the ward.D2 method with 10,000
bootstraps [39]. Methylation levels of individual CpG sites
within a given region were used for statistical comparisons
within tissues, while the average level for a given region in
each tissue was used when comparing across tissue types.
For statistical comparisons, TSS regions were defined as
300 bp upstream to 200 bp downstream of the annotated
TSS. Gene body regions were defined as the annotated
gene region excluding the 5’ 5 % of the gene body, in order
to avoid the TSS region. CpG, TpG, and ApG densities
were compared across genomic regions by calculating the
number of sites within a given set of regions and normal-
izing to a length of 100 bp. Normality of data was tested
using the Shapiro-Wilk or Kolmogorov-Smirnov normal-
ity test when appropriate, and an F-test was used to
test for equality of variance between groups. Significant
differences between groups were determined using the
Student’s t-test for normally distributed data, and the
Wilcoxon signed-rank test for non-normally distributed
data. Spearman’s rank correlation analysis was performed
for all correlation analysis. Gene regions with a minimum
of 2 high confidence CpG sites were used when correlat-
ing CpG methylation with CpG density and/or expression,
with the exception of CpG islands (CGIs), which were re-
quired to contain a minimum of 4 high confidence CpG
sites due to their higher coverage in the RRBS datasets.
WGS, Targeted Control Data Analysis, and SNP Validation
Whole genome sequencing (WGS) Illumina reads from
the same individual were downloaded from the Euro-
pean Nucleotide Archive [ENA:PRJEB9115] and aligned
against the swine reference for SNP discovery. Reads
were trimmed with Trim Galore v.0.1.4 to a Phred qual-
ity > 20 and minimum length of both pairs of 25 bp,
and the quality trimmed reads were aligned to the swine
reference genome using the unique alignment option of
Mosaik Aligner v.1.1.0017 [40]. PCR duplicates were re-
moved using Picard version 1.99 [41] and re-aligned
with GATK version 2.3-9-ge5ebf34 [42]. The final align-
ment of uniquely aligned paired-end reads had an aver-
age coverage of 25X with 2.04 GB of the genome
covered. Additionally, the targeted control datasets for
each tissue were combined, resulting in a total of 136.6
million raw reads. Raw reads were trimmed as described
above. Trimmed reads were aligned to the swine refer-
ence genome with bowtie2 v.2.2.3 in –end-to-end mode
and setting the –N option to 1 and the –L option to 20.
The resulting alignments were filtered for uniquely
aligned reads, and realigned using GATK v.2.3-9-
ge5ebf34. The final alignment of uniquely aligned reads
had an average coverage of 12.7X with 0.15 Gb of the
genome covered. The resulting targeted control and
WGS alignments were used for variant calling using
GATK v.3.3-0 with the –stand_call_conf option set to
50, the –stand_emit_conf option set to 20, and the
-dcov option set to 200. Variants were filtered so that
only SNPs with a read depth between 1/3 and 1.75 times
the average coverage (4 – 20 reads for targeted control,
8 – 44 reads for WGS) and a minimum mapping quality
of 20 were used for analysis. Depth cutoffs were based
on previous studies using similar restrictions [43–45].
Due to the difference in average depth between the
WGS and targeted control datasets, a ratio of the aver-
age coverage was used to determine the minimum
depth cutoff, making sure the minimum number of
reads was ≥ 4. Additionally, while many studies use a
maximum depth of 2x the average coverage, a conserva-
tive cutoff of 1.75x was used in order to reduce the
number of false positives detected due to the higher
coverage. These sites were removed from the RRBS
dataset before analysis.
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RNA-Seq Data Analysis
An average of 45.8 million raw stranded paired-end
reads were produced for each sample, ranging from 39.6
to 52.5 million (Additional file 1: Table S1). Raw reads
were trimmed sequentially for adapter contamination,
A-tails, and minimum quality score (20) and minimum
length (20 bp) as described above. Unpaired reads were
retained with a minimum length of 35 bp. Trimmed
paired and unpaired reads were aligned to the swine ref-
erence genome using Tophat v.2.2.10 [46]. Tophat ana-
lysis included a pre-alignment to the reference genome
to filter out reads extending the maximum number of
alignments (-M option) followed by alignment to the
Ensembl swine reference transcriptome (-G) and align-
ment to the genome. The number of allowed alignment
hits (-g option) was 20 for differential expression ana-
lysis and one for allelic expression (unique alignments
only). Furthermore the –read-realign-edit-dist option
was set to 0, the –mate-inner-dist option to 120, the
–mate-std-dev option to 260 and included the fr-
firststrand option. Aligned bam files were assessed for
differential gene expression using cufflinks v.2.2.1 [47].
First cufflinks was used to assemble transcripts for each
sample using the fr-firststrand option, followed by Cuff-
merge to merge the assembled transcripts from all sam-
ples with the reference transcripts. Cuffquant was used
to pre-compute gene expression levels for each sample
using the –u option, which more accurately weights reads
mapping to multiple locations, and the fr-firststrand
option. Finally, Cuffnorm was used to produce gene
expression levels normalized for library size by setting
the –library-norm-method to geometric and including
the fr-firststrand option.
Allelic Expression Analysis
Allelic expression analysis was performed following pre-
viously published protocols [48]. The RNA-seq align-
ments were re-aligned for allelic expression with GATK
v2.3-9 and PCR duplicates were removed using Picard
v.1.119. WGS data from the same individual [ENA:PR-
JEB9115] was aligned, PCR duplicates removed, and rea-
ligned as described above, and variants were filtered so
that only heterozygous SNPs with a read depth between
8 (1/3 the average coverage) and 44 (1.75 times the aver-
age coverage) and a minimum mapping quality of 20
were used for analysis. The resulting alignment was used
for variant calling using GATK v.3.3-0 with the –stand_
call_conf option set to 50, the –stand_emit_conf option
set to 20, and the –dcov option set to 200. Variation
calling in the RNA-seq alignment was performed using
SAMtools mpileup v.0.1.18 [49] with a minimum of 10
reads/site and a minimum quality score of 20. The sama-
se.pl script [48] was used to parse the mpileup file, map
each variant to an annotated gene, and conduct a
binomial test for allele specific expression (ASE) with
the –calculate_ase_normal option, and the –r option set
to 0.5. ASE positions were removed if they were found
to be within 20 bp of another SNP, within 15 bp of an
INDEL, had a low calling indication or ratio of <0.3 be-
tween SNP reads. Only genes in which all SNPs were
found to be ASE SNPs (Benjamini-Hochberg corrected q
< 0.05) were used for analysis. GO term and KEGG
pathway enrichment analysis was performed for genes
displaying ASE in at least 2 tissues using DAVID v6.7
[50, 51] in order to limit any tissue specific bias, with
only significantly enriched GO terms and KEGG path-
ways reported (Benjamini-Hochberg corrected q < 0.05).
The background for GO term and KEGG pathway en-
richment analysis was all genes tested for ASE (genes
containing SNPs).
Independent validation of gene expression and DNA
methylation patterns
In order to validate the results presented in this study,
DNA was extracted from 3 tissues (liver, muscle, and
spleen) collected from an unrelated adult male Duroc
(3 years old) using the DNeasy tissue kit (Qiagen, Venlo,
NL, USA). The purified DNA was sent to BGI (China)
for RRBS library production as described above. The
RRBS libraries were produced using 40 – 220 bp and
220 – 400 bp fragments and sequenced to varying
depths using both paired- and single-end sequencing
(Additional file 2: Table S2). Raw reads were trimmed,
aligned, and methylation levels determined as described
above. In addition, overlaps between paired-end reads
were removed using the BamUtil v.0.5.7 clipOverlap
function after alignment and before methylation calling
[52], in order to avoid counting overlapping reads twice.
Validations were performed by determining the 10 CpG
sites showing the largest increase and decrease in methy-
lation level for each tissue comparison from the adult fe-
male Duroc (liver vs. muscle, liver vs. spleen, and spleen
vs. muscle) and comparing them to the differences ob-
served at the same sites (60) in the validation dataset.
Sites returning a value of –infinity or infinity for log2
fold change (a change from the umethylated (0 %) to
methylated state between tissues) were given a value of
-6 and 6 for correlation analysis, respectively. This value
was chosen in order to give these sites the largest fold
change difference of the sites tested.
Total RNA was isolated with the RNeasy mini kit
(Qiagen, Benlo, NL, USA). The purified RNA was sent
to the HTS lab (University of Illinois, Urbana, IL, USA)
for TrueSeq Stranded RNA-seq library production as
described above. The RNA-seq libraries were sequenced
to an average depth of 35.2 million paired-end reads
(Additional file 2: Table S2). The raw reads were
trimmed, aligned, and expression levels determined as
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described above. Validations were performed by calculat-
ing the log2 fold change from the 10 most up- and
downregulated genes between each tissue comparison
from the adult female Duroc and comparing them to the
differences observed for the same genes (60) in the
validation dataset.
Results
Whole genome sequencing and targeted control libraries
for CpG site validation
A total of 1,140,814 CpG sites were covered by at least
10 reads in one of the tissue samples analyzed (high con-
fidence sites). These sites were validated using a WGS
dataset from the same individual to test for SNPs, since
CpG dinucleotides mutate at a high rate due to the
deamination of 5-methylcytosine to thymidine [53] and
such SNPs could potentially bias the methylation results.
Surprisingly, only 334,598 (29.33 %) of the high confi-
dence sites met the depth requirements for SNP detec-
tion (see Methods), with 5,515 sites (1.65 %) found to
contain SNPs. In order to increase the coverage of high
confidence sites for CpG site validation, a control dataset
was produced in the same manner as the RRBS datasets,
without bisulfite treatment (targeted control). A total
of 988,885 (86.68 %) of the high confidence sites met
the depth requirements for SNP detection in the tar-
geted control dataset and were tested for CpG site
validation. Of these sites, 6,585 (0.67 %) were found
to contain SNPs.
In order to investigate the low coverage of CpG sites in
the WGS dataset, read depth analysis was performed on
both the targeted control and WGS datasets. While a nor-
mal distribution was observed for the WGS dataset when
considering all genome positions (Additional file 3: Figure
S1a), the coverage of high confidence CpG sites revealed a
skewed pattern, with the majority of sites covered at levels
below the threshold for SNP calling (Additional file 3:
Figure S1b). The opposite pattern was observed in
the targeted control dataset, with, as expected from a
reduced library, a skewed distribution over the whole
genome and a more even distribution over the high
confidence CpG sites (Additional file 3: Figure S1c,
d). When assessing high confidence CpG sites covered
in both datasets, 5,017 CpG sites were found to contain
SNPs in one of the datasets, of which 1,872 (37.31 %) were
detected in both datasets. In total, 10,227 CpG sites were
found to contain SNPs in the two datasets combined, and
were excluded from further analysis.
Genomic location of CpG sites targeted by RRBS
Of the CpG sites remaining after SNP removal, a total of
529,902 sites were covered in all samples and used for
comparative analyses (Additional file 4: Table S3). While
RRBS has been used extensively in human and mouse
studies [26, 54], the use of this technology has been lim-
ited in pigs to date [22]. Therefore, attention was focused
on the distribution of the covered CpG sites in relation to
genomic features of interest. Of the CpG sites covered in
all samples, the majority were associated with CGIs and
CpG island shores (CGS; 64 %; Additional file 5: Figure
S2a) or gene bodies (including up to 10 kb upstream of
TSS; 66 %; Additional file 5: Figure S2b). In addition,
45.59 % of the CpG sites associated with CGIs were also
associated with genic regions, and vice versa (Additional
file 5: Figure S2c). The frequency of methylated CpG sites
formed a bimodal distribution typical of previously re-
ported RRBS studies (Additional file 5: Figure S2d) [55].
As expected, the number of covered CpG and non-
CpG sites on each chromosome was positively corre-
lated with the number of chromosomal CpG sites
(Spearman’s Rho > 0.85, p < 0.00001; Additional file 5:
Figure S2e, f ), indicating a lack of chromosomal bias.
Genome-wide CpG methylation and density patterns in
relation to genomic features
CpG methylation levels (defined as the ratio of methyl-
ated reads/total reads at a given site) were similar be-
tween tissues, with an average methylation level of
41.39 % ranging between 39.52 % in muscle and 44.75 %
in spleen (Additional file 4: Table S3). On average
18.02 % of CpG sites were unmethylated (0 %) in each
tissue, ranging from 13.09 % in spleen to 21.5 % in lung,
and 57.73 % of CpG sites were methylated (>10 %) in
each tissue, ranging from 56.17 % in lymph node to
60.9 % in spleen (Additional file 6: Table S4). When
comparing CpG methylation levels across chromosomes,
a significantly higher average methylation level was ob-
served for the X chromosome (48.46 %) than the auto-
somes (40.94 %) across all tissues (p < 0.0001; Fig. 1a,
Additional file 7: Table S5). This translated to a signifi-
cantly lower percentage of unmethylated (0 %) CpG sites
on the X chromosome compared to the autosomes (6.16
and 18.28 %, respectively, p < 1×10–9; Fig. 1b, Additional
file 8: Table S6), and a significantly higher percentage of
methylated (>10 %) CpG sites (81.93 and 57.28 %, respect-
ively, p < 1×10–5; Fig. 1c, Additional file 9: Table S7). The
increased CpG methylation level, reduced proportion of
unmethylated CpG sites, and increased proportion of
methylated CpG sites on the X chromosome were not
observed in the male samples used for validation (see
Methods; Additional file 10: Table S8), suggesting that
the observed differences in relation to autosomes in
the female samples is a result of X chromosome inactiva-
tion. Surprisingly, chromosome 11 was found to have the
highest CpG methylation level of all the chromosomes in
each tissues analyzed (Fig. 1a, Additional file 7: Table S5),
however, this was not associated with the same decrease in
unmethylated and increase in methylated CpG sites as
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observed on the X chromosome (Fig. 1b, c, Additional file
8: Table S6, Additional file 9: Table S7).
Profiling CpG methylation patterns within genomic
regions revealed similar patterns across all tissue types
(Fig. 2a, Additional file 4: Table S3). As expected, signifi-
cantly lower CpG methylation levels were observed within
CGIs compared to CGS both across and within all tissue
samples (p < 0.001; Fig. 2a, Additional file 4: Table S3). Con-
sistent with previous human studies [56], CGIs and CGS
10 kb upstream of TSS were hypomethylated compared to
CGIs and CGS within gene bodies (p < 0.001; Fig. 2d). In
addition, significantly higher levels of methylation were
observed in introns compared to exons (p < 1×10−9; Fig. 2a,
Additional file 4: Table S3). Each tissue also displayed a
similar dip in methylation centered at the TSS (Fig. 2c) that
increased towards the 3’ end of gene bodies (Fig. 2b). Des-
pite the similarities observed in global CpG methylation
patterns, tissue specific methylation patterns were still ap-
parent (Fig. 2g). Surprisingly, tissues with similar functions,
such as muscle (skeletal muscle and heart) and immune
tissues (lymph node and spleen) did not cluster together.
As CpG methylation is known to be negatively corre-
lated with CpG density [57], the number of CpG sites in
the pig genome were profiled in relation to TSS and
CGIs, regions in which reduced CpG methylation was
detected in all tissue types. As expected from the defin-
ition of CGIs, CGIs on average had a higher density of
CpG sites than CGS, highlighted by a peak in CpG dens-
ity at the CGI CGS boundaries (Fig. 2f ). Additionally, a
higher CpG density was detected within CGIs located
within 10 kb upstream of TSS compared to those within
gene bodies, with the opposite pattern being observed
for CGS (p < 1×10−15; Fig. 2f ). Surprisingly, while a nega-
tive correlation between CpG density and methylation
was observed in CGIs located within 10 kb upstream of
TSS (Spearman’s rho −0.30 to−0.33, p < 1×10−15) and
within gene bodies for all tissue types (Spearman’s
rho −0.52 to−0.54, p < 1×10−15; Fig. 2d, f ), a positive
correlation between CpG density and methylation was
observed in CGS within 10 kb upstream of TSS
(Spearman’s rho 0.22 to 0.25, p < 1×10−15) and within
gene bodies for all tissue types (Spearman’s rho 0.21
to 0.24, p < 1×10−15; Fig. 2d, f ). The same correlations
were observed when comparing all CGI (Spearman’s
rho −0.52 to−0.54, p < 1×10−15) and CGS in the pig
genome (Spearman’s rho 0.22 to 0.25, p < 1×10−15).
Fig. 1 Distribution of CpG methylation across chromosomes. a Average CpG methylation levels of all 18 autosomes and the X chromosome across all
tissues. Average distribution of b unmethylated (0 %) and c methylated (>10 %) CpG sites across all tissues for all 18 autosomes and the
X chromosome. * denotes p-value < 0.0001, ** denotes p-value < 1×10−5, *** denotes p-value < 1×10−9
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Fig. 2 CpG methylation in relation to genomic features across tissue types. a Average CpG methylation levels for various genomic features. CpG
methylation levels in relation to (b) genic regions, (c) TSS, (d) CGI and CGS within gene bodies and up to 10 kb upstream of TSS. Average CpG density/
100 bp bin in relation to (e) TSS and (f) CGI and CGS within gene bodies at 10 kb upstream of TSS. X axis represents distances in bp. g Cluster analysis
based on methylation levels at all shared CpG sites, with red numbers indicating the approximately unbiased p-value, and green numbers indicating
the bootstrap probability value. * denotes p-value < 0.001, ** denotes p-value < 1×10−10
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Increased CpG density was also observed in relation to
TSS, with a negative correlation between CpG density and
TSS CpG methylation observed in all tissue types (Spear-
man’s rho −0.28 to−0.31, p < 1×10−15; Fig. 2c, e), as is con-
sistent with previous human studies [58].
Non-CpG methylation distributed in a non-random pat-
tern across tissue types
In addition to CpG sites, a total of 5,029,035 non-CpG
sites were covered by at least 10 reads in at least one
sample (high confidence sites). Non-CpG sites covered
by either the targeted control or WGS datasets (44.18 %
of high confidence sites) were evaluated for SNPs, in-
cluding the presence of a guanine in the 3’ adjacent base
that would result in the presence of a CpG site. Of these,
4,123 (0.19 %) were shown to contain SNPs and ex-
cluded from further analysis. A total of 2,191,233 non-
CpG sites were covered in all samples after SNP removal
and used for comparative analysis (Additional file 11:
Table S9). Of the covered non-CpG sites, 63.77 % were
CHH sites (H representing nucleotides C, T, or A), with
the remainder being CHG sites. The non-CpG methyla-
tion levels were similar across all tissue types (<1 %) and
consistent with what has been previously reported in por-
cine non-neuronal tissue (Additional file 11: Table S9) [22].
Additionally, significantly higher levels of methylation were
observed at CHG compared to CHH sites when comparing
across all tissues (p < 1×10−11; Fig. 3a) and within tissues
(p < 1×10−16; Additional file 12: Table S10).
No differences in terms of non-CpG methylation were
observed between the X chromosome and the autosomes,
with an average of 79.01 % of non-CpG sites unmethylated
(0 %) and 17.79 % methylated (>1 %) across all tissue types
(Additional file 13: Table S11, Additional file 14: Table
S12), suggesting non-CpG methylation is not involved in
X chromosome inactivation in adult somatic tissues.
When comparing non-CpG methylation across genomic
regions, a pattern similar to that for CpG sites within
CGIs, CGS, introns, and exons was detected, albeit at a
much lower methylation level (Fig. 3b). As with CpG sites,
Fig. 3 Non-CpG methylation across genomic features. Average methylation level of (a) CHG and CHH sites, and (b) non-CpG sites in relation to genomic
features. c Cluster analysis based on methylation levels at all shared non-CpG sites, with red numbers indicating the approximately unbiased p-value, and
green numbers indicating the bootstrap probability value. d Non-CpG methylation levels in relation to gene bodies and TSS. X axis represents distances
in bp. * denotes p-value < 0.01, ** denotes p-value < 0.001, *** denotes p-value < 1×10−10
Schachtschneider et al. BMC Genomics  (2015) 16:743 Page 9 of 18
significantly lower non-CpG methylation was observed
within CGI compared to CGS when comparing across
all tissues (p < 0.01) and within all tissues except liver
(p < 0.001; Fig. 3b). In addition, significantly higher levels
of non-CpG methylation were observed in introns com-
pared to exons when comparing across all tissues (p <
0.01). When comparing within tissue types, significant dif-
ferences were observed in lymph node, muscle, and spleen
(p < 0.01; Fig. 3b). Cluster analysis based on non-CpG
methylation showed a different pattern than CpG methy-
lation, with immune tissues (lymph node and spleen)
clustering together, and fat and lung clustering separately
from all other tissues (Fig. 3c). In addition, when non-
CpG methylation was profiled in relation to gene bodies,
lower methylation at the 5’ end of genes that reached its
lowest point at the TSS was observed (Fig. 3d).
Gene expression, DNA methylation, and CpG density
provide potential link to adaptive evolution
Similar genome wide expression levels were observed
between all tissue types, with an average of 27.57 % of
genes displaying no expression (Fig. 4a). The majority of
Fig. 4 CpG Methylation and density are correlated with gene expression. a Gene expression profile of each tissue type and number of genes
expressed at each level in all tissues. b Negative correlation between CpG methylation and gene expression at TSS. c Positive correlation between CpG
methylation and gene expression within gene bodies. d Positive correlation between CpG density and gene expression at TSS. e Negative correlation
between gene expression and TpG density at TSS. f Negative correlation between gene expression and ApG density at TSS. X axis represents distances
in bp
Schachtschneider et al. BMC Genomics  (2015) 16:743 Page 10 of 18
profiled genes were predominantly expressed at levels
below 100 fragments per kilo bases of exons per million
mapped reads (FPKM; 69.61 %), with genes expressed at
levels above 100 FPKM representing an average of
2.82 % in all tissues (Fig. 4a). Despite the similarity in
the number of genes detected at each expression level,
pairwise comparisons revealed on average, between 48
and 68 % of genes expressed at a given level in one
tissue were found to be expressed at the same level in
another tissue, with < 15 % shown to be expressed at the
same level in all tissues, highlighting the differences in
gene expression between tissue types (Fig. 4a). This find-
ing was in contrast to a high number of genes found to
have no expression in pairwise comparisons (average of
84.28 %) and each of the eight tissue types (44.86 % of
non-expressed genes; Fig. 4a).
DNA methylation has been associated with gene ex-
pression in a variety of species and cell types [59–61].
As the number of genes with expression levels above
100 FPKM is on average an order of magnitude lower
than that for the other expression levels, this range was
excluded from further methylation analysis. Consistent
with previous reports [59], this study revealed a negative
correlation between TSS CpG methylation and gene ex-
pression (Spearman’s rho −0.20 to−0.25, p < 1×10−15;
Fig. 4b, Additional file 15: Figure S3), and a visible but
statistically weak positive correlation between gene
body CpG methylation and expression for all tissue
types (Spearman’s rho 0.05 − 0.12, p < 0.01; Fig. 4c,
Additional file 16: Figure S4).
In addition to the negative correlation between TSS CpG
methylation and expression, TSS CpG methylation and
density were also negatively correlated (Fig. 2c, e). These
results led to the hypothesis that TSS CpG density is posi-
tively correlated with gene expression. To test this hypoth-
esis, TSS CpG density was compared to gene expression
for all tissue types. As hypothesized, the results revealed a
positive correlation between TSS CpG density and
gene expression for all tissue types (Spearman’s rho
0.32 − 0.35, p < 1×10−15; Fig. 4d, Additional file 17:
Figure S5), despite the low number of shared genes at
each expression level.
It was further hypothesized that the correlation between
TSS CpG density and expression is due to the high muta-
tion rate of cytosines in CpG compared to non-CpG con-
text [62], with transition mutations (C to T) being more
common than transversions (C to A or G). Therefore, a
higher TpG (and to a lesser extent ApG) site density
would be expected in the TSS region of lowly compared
to highly expressed genes, resulting in negative correla-
tions between expression and the density of these sites at
the TSS. As a higher number of GpG sites are likely to be
found in GC rich genes, which are known to be highly
expressed [63, 64], these sites were not considered for
correlation analysis. As hypothesized, the results revealed
a negative correlation between TSS TpG density and gene
expression (Spearman’s rho −0.23 to−0.25, p < 1×10−15;
Fig. 4e, Additional file 18: Figure S6), in addition to a
weaker negative correlation between TSS ApG density
and gene expression in all tissues (Spearman’s rho −0.05
to−0.08, p < 1×10−15; Fig. 4f, Additional file 19: Figure S7),
suggesting that the lower TSS CpG density in lowly
expressed genes is predominantly due to the deamination
of 5-methylcytosine to thymidine over time.
DNA methylation patterns associated with allelic
expression
In addition to changes in methylation associated with
expression, previous reports have also detected differen-
tial methylation between alleles of genes displaying ASE
[65]. While distinguishing differences in methylation
patterns between alleles was not within the scope of this
project, global methylation patterns of ASE genes were
profiled. ASE genes were defined as genes in which one
allele was expressed at a significantly higher level than
the other (q < 0.05). A total of 3,530 genes contained
SNP sites and were tested for ASE (see Methods). Of
these, 758 demonstrated ASE patterns in at least one tis-
sue type, with an average of 178 genes/tissue (Table 1).
Of the 758 ASE genes, 476 displayed tissue specific ASE,
resulting in an average of 33.36 % of ASE genes in a
given tissue being tissue specific (Table 1). ASE genes
were compared to a list of known human (245) and
porcine (30) imprinted genes downloaded from the
imprinted gene database [66]. Of the known human and
porcine imprinted genes, 25 and 4 contained SNPs in
our dataset and were assessed for ASE, respectively. Of
these genes, 7 human and all porcine imprinted genes
showed patterns of ASE in at least one tissue, respect-
ively, demonstrating the ability of the analysis to detect
known imprinted genes. Additionally, a total of 64 genes
were found to be mono-allelically expressed (expressed
from only one allele) in at least one tissue type, with an
average of 24 genes/tissue (Table 1). Of the 64 mono-
Table 1 Number of ASE and mono-allelic genes detected in
each tissue
ASE Unique ASE Mono-allelic Unique Mono-allelic
Fat 225 75 25 3
Heart 138 43 24 2
Kidney 217 73 24 3
liver 210 80 21 2
Lung 195 68 25 5
Lymph Node 135 35 27 3
Muscle 135 53 25 6
Spleen 172 49 24 3
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allelic expressed genes, 27 displayed tissue specific mono-
allelic expression, resulting in an average of 13.85 % of
mono-allelic expressed genes in a given tissue being
unique to that tissue (Table 1). This translates to a higher
average proportion of tissue specific ASE genes than
mono-allelic expressed genes (33.36 and 13.85 %, respect-
ively, p < 0.00001; Table 1)
As imprinted genes have been shown to be essential
for metabolic, regulatory, and developmental processes
[67], the functional characteristics of porcine ASE genes
were assessed using GO term and KEGG pathway en-
richment analysis. GO terms and KEGG pathways con-
taining significantly more ASE genes than expected by
chance (q < 0.05) were considered enriched in each tis-
sue. The 282 genes displaying ASE in at least 2 tissues
were used for GO term and KEGG pathway analysis in
order to limit any tissue specific bias. A total of 17 GO
terms and 9 KEGG pathways were enriched for ASE genes
(Additional file 20: Table S13). Of the enriched GO terms,
6 related to the regulation of cell death and apoptosis, 6 to
response to oxygen species and oxidative stress, 4 to the
formation of protein oligomers, and 1 related to the regu-
lation of cell proliferation (Additional file 20: Table S13).
Of the enriched KEGG pathways, the majority were in-
volved in metabolism, with 2 related to genetic informa-
tion processing (1 at the transcriptional and 1 at the
translational level; Additional file 20: Table S13). Overall
the results suggest that porcine ASE genes are involved in
metabolic and regulatory processes.
In order to determine whether differences in CpG
methylation were apparent in these genes, both ASE and
mono-allelic expressed genes were profiled and com-
pared to the average level for all expressed genes (Fig. 5).
Although the average methylation levels across all tissue
types revealed hypermethylation within gene bodies of
ASE and mono-allelic expressed genes (Fig. 5a, b), ex-
pression profiles also revealed on average higher expres-
sion levels in ASE (median FPKM of 26.49) and mono-
allelic expressed genes (10.59) compared to all genes
(4.08; Fig. 5c). Therefore, observed differences in CpG
Fig. 5 CpG methylation of ASE genes. a CpG methylation in gene bodies of ASE and mono-allelic expressed genes compared to all expressed
genes. b Differences in CpG methylation at TSS of ASE and mono-allelic expressed genes compared to all expressed genes. X axis represents distances
in bp. c Expression profile of ASE and mono-allelic expressed genes compared to all expressed genes
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methylation between ASE, mono-allelic, and all expressed
genes can be explained by differences in expression.
Independent validation of gene expression and DNA
methylation patterns
In order to validate the gene expression and DNA
methylation patterns reported, RRBS and RNA-seq was
performed on liver, muscle, and spleen from an unre-
lated adult male Duroc (validation dataset) and com-
pared to the results from this study. The log2 fold
changes in gene expression from the 10 most up- and
downregulated genes between each tissue comparison
from the adult female Duroc (liver vs. muscle, liver vs.
spleen, and spleen vs. muscle) were compared to the dif-
ferences observed for the same genes (60) in the valid-
ation dataset. The results revealed the same directional
change in expression between tissues for all genes tested
(Additional file 21: Figure S8a, b, and c). In addition, the
log2 fold changes were highly correlated between the adult
female Duroc and the validation dataset (Spearman’s Rho
0.899, p < 1×10−15; Additional file 21: Figure S8d), further
validating the gene expression results presented here.
Validation of the DNA methylation results was per-
formed by determining the 10 CpG sites displaying the
largest increase and decrease in methylation level for each
tissue comparison from the adult female Duroc and com-
paring them to the differences observed for the same sites
in the validation dataset. The results revealed the same
directional change in methylation level between tissues for
56 of the 60 sites tested (Additional file 22: Figure S9a, b,
and c). Three of the 4 sites that did not display the same
directional change were unmethylated in both tissues in
the validation dataset, while the other displayed an oppos-
ing directional change when comparing spleen and liver
(64.9 % lower and 14.04 % higher methylation in the adult
female Duroc and validation dataset, respectively). It is
also worth noting that 3 of the 4 differing sites were from
comparisons involving the spleen, which is more likely to
have varied methylation due to environmental differences
resulting in differing immune system status between these
individuals. In addition, the log2 fold changes in methyla-
tion were highly correlated between the adult female
Duroc and the validation dataset (Spearman’s Rho 0.831,
p < 1×10−15; Additional file 22: Figure S9d), further valid-
ating the DNA methylation results presented here.
Discussion
As the evidence for linkage between epigenetics and
health continues to grow, there is an increasing need for
a better understanding of how these patterns affect cel-
lular processes, as well as how they can be influenced by
environmental signals. While profiling these patterns in
human cells is essential to understanding the mecha-
nisms behind these diseases and how they contribute to
human health, an understanding of the functional simi-
larities and differences between epigenetic patterns in
humans and model organisms used to study human
disease is critical. This project utilized tissues from the
same individual chosen for production of the swine ref-
erence genome (Sscrofa10.2), providing transcriptional
and DNA methylation datasets for the biomedical com-
munity directly relatable to current genomic resources.
One disadvantage of this study was the inability to
infer cell type specific methylation patterns, as DNA
methylation patterns are known to vary across cell types
[68]. However, while the majority of human samples
profiled in studies such as the human ENCODE project
consist of cell lines, tissue specific methylation patterns
are useful to the swine biomedical community due to
the current lack of standardized commercially available
porcine cell lines. Indeed, while there are > 1,100 human
cell lines available from ATCC [69], only 8 porcine cell
lines (3 kidney epithelial, 3 alveolar macrophage, and 2
fibroblast cell lines) are currently available. Furthermore,
altered methylation patterns have been observed in
transformed cell lines as well as lines with high numbers
of passages [70–73]. Therefore the results presented
here are likely to be more representative of in vivo states
than those derived from transformed cell lines with high
passage rates.
When investigating genome-wide DNA methylation
patterns, it is important to consider which technique is
most appropriate for a given study. Whole genome
bisulfite sequencing (WGBS) is quickly becoming the
standard technology used to detect genome-wide methy-
lation patterns in humans and mice due to its ability to
cover the vast majority of the CpG and non-CpG sites in
a genome. Therefore the ability of this study to investi-
gate genome-wide DNA methylation patterns is limited
to the subset of sites located within the RRBS target
regions. Additionally, the observed methylation patterns
in these regions tend to underestimate genome-wide
methylation levels and the frequency of methylated CpG
sites, as RRBS targets CpG rich regions throughout the
genome, and methylation is negatively correlated with
CpG density. However, the increased costs associated
with the use of WGBS, such as the need to sequence the
entire genome to an appropriate depth compared to se-
quencing < 2 % of the genome here, limits its use in this
and many other studies. Additionally, the consistent en-
richment of CpG sites of interest, such as those located
within CGIs, was demonstrated previously in a porcine
study using RRBS to assess altered intestinal DNA
methylation patterns associated with preterm birth and
development [22]. This study further demonstrates the
ability of RRBS to target CpG sites of interest in pigs,
with 73 % of the CpG sites covered across tissue types
located within either CGIs or gene regions. Additionally,
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the distribution of covered CpG sites revealed a bimodal
distribution typical of previous human RRBS studies
[55]. These patterns, as well as the confirmation of tissue
specific DNA methylation changes in the validation
dataset, confirm RRBS is effective in targeting and de-
tecting relevant methylation levels in CpG rich regions
of interest in pigs, further validating it as a suitable tech-
nique for studying porcine genome-wide methylation
patterns.
Given the fact that CpG dinucleotides mutate at higher
rates due to the deamination of 5-methylcytosine to thy-
midine, it is important to remove SNP sites before analysis
of methylation data, as their inclusion in downstream
analyses could result in incorrect methylation estimates,
ultimately biasing results, particularly for studies in which
differential methylation analysis is performed. In this study
the ability of a targeted control library to detect SNPs at
CpG sites was assessed. This targeted control dataset was
able to cover a significantly higher percentage of the CpG
sites used for methylation analysis than the WGS dataset
(86.68 % compared to 29.33 %), despite the high average
coverage (25×) of the WGS dataset. While surprising, the
low coverage of CpG rich regions by the WGS dataset is
most likely due to the GC-bias of Illumina sequencing
data. Therefore, the utilization of targeted control datasets
as described here provides effective detection of SNPs at
CpG sites targeted by RRBS studies compared to trad-
itional WGS datasets used for SNP detection. However, as
the total number of SNPs detected by the targeted control
dataset represents a relatively small percentage of the total
CpG sites assessed for methylation analysis (0.67 %), use
of a control dataset is probably not necessary for genome
wide studies such as this, but could be important in stud-
ies performing site specific methylation comparisons. It is
also important to note that in addition to directly effecting
detected methylation levels at CpG sites, SNPs at CpG
sites also have the potential to affect methylation levels of
surrounding sites by altering the GC content and CpG
density of the region. While not investigated here, targeted
control libraries could be used to investigate the effects of
SNPs on regional methylation levels in studies consisting
of individuals with diverse variation.
The observed increased CpG methylation level, as well
as the increased proportion of methylated (>10 %) and
decreased proportion of unmethylated CpG sites on the X
chromosome compared to the autosomes are similar to
patterns observed in human female samples [74], suggest-
ing CpG methylation is important in porcine X chromo-
some inactivation. Additionally, no significant differences in
non-CpG methylation distribution were observed between
the X chromosome and the autosomes, suggesting non-
CpG methylation does not play a role in X-inactivation in
adult somatic tissues. While the majority of the observed
methylation patterns were consistent with reported patterns
in human cells [55], the higher CpG methylation within in-
trons compared to exons is in contrast to reports in human
cell lines [60, 75]. At this time it is unclear whether the op-
posing patterns observed between porcine tissues and hu-
man cell lines is due to differences in the evolution of these
patterns in the two species, differences in cell line vs tissue
patterns, or both. However, these results ultimately support
previous reports suggesting a role of CpG methylation
in defining intron exon boundaries and regulating
splicing [76, 77].
Recently non-CpG methylation has been demonstrated
to be correlated with gene expression in embryonic stem
cells, induced pluripotent stem cells, and oocytes of
many mammalian species [55, 78, 79], as well as in
mammalian neuronal tissue [80, 81]. Additionally, low
levels of non-CpG methylation have also been reported
in human and porcine non-neuronal somatic tissues,
with no known functional relevance [22, 55]. Here we
report non-CpG methylation for all eight somatic tissue
types distributed in a non-random fashion, suggesting a
relationship between non-CpG methylation and genomic
features. The increased non-CpG methylation within
CGS compared to CGIs, and introns compared to exons
was similar to the pattern observed for CpG methyla-
tion, albeit at a much lower level. While these differ-
ences were not significant in all tissue types, this trend
was observed for each tissue. Reduced non-CpG methy-
lation toward the 5’ end of genes was also detected, with
the lowest level found at the TSS. While similar correla-
tions have been reported in human pluripotent cells
[55], these patterns have not been previously reported in
somatic non-neuronal tissues. Although it has been
reported that RRBS datasets are capable of detecting a
representative sample of non-CpG sites throughout the
human genome [55], it is important to note that the sites
covered in this study represent only 0.21 % of all non-
CpG sites in the pig genome, and therefore more exten-
sive studies are required to confirm whether these results
are representative, and whether non-CpG methylation
plays a functional role in these tissues.
Although DNA methylation patterns are known to
form tissue specific patterns as cells undergo differenti-
ation [82], the results from this study revealed similar
genome-wide DNA methylation patterns across multiple
tissue types in relation to CGI, CGS, TSS, and gene bod-
ies. It is important to note that while the genomic
methylation patterns in relation to genic regions were
similar for all eight tissues, the resulting cluster analysis
suggests that tissue specific patterns are still present.
While tissues with similar functions, such as muscle
(skeletal muscle and heart) and immune tissues (lymph
node and spleen) did not cluster together when assessing
CpG methylation, the immune tissues did cluster to-
gether when assessing non-CpG methylation, highlighting
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the differential clustering of tissue types when assessing
CpG and non-CpG methylation. Additionally, the
smaller height observed for the CpG cluster suggests
that tissue types are more similar in terms of CpG
methylation, and that there are differences in how these
patterns vary across tissue types. However, the lack of
CpG methylation based tissue clustering by function or
cell lineage is surprising, and could be due to a number
of factors including the use of tissue samples as opposed
to purified cell lines, or the reduced nature of the RRBS
datasets. Future profiling of these tissues in additional
individuals will help provide further insights into the re-
latedness of these tissues in terms of CpG and non-CpG
methylation, and how they compare to known patterns
in humans.
As the number of studies reporting CpG methylation
associated with gene expression continues to increase, it
is becoming increasingly apparent that the genomic lo-
cation of CpG sites is critical in determining what effect
methylation has on expression. Both a negative correl-
ation between TSS CpG methylation and gene expres-
sion, as well as a positive correlation between gene body
CpG methylation and gene expression were observed.
While the observed positive correlation between gene
body CpG methylation and gene expression was statisti-
cally weak, this result could be due to the lower average
coverage of CpG sites within gene body regions (2.18 %)
compared to TSS (10.17 %), resulting in lower accuracy
when correlating CpG methylation with expression of
individual genes. Overall, these results are consistent
with previous reports in human somatic tissues [59],
supporting the hypothesis that porcine genomic CpG
methylation displays similar genomic distribution and
functional patterns as human cells.
Consistent with previous reports in humans [57, 58], an
increase in CpG density at the TSS of pig genes, as well as
a negative correlation between CpG density and methyal-
tion at TSS and CGIs was observed. Surprisingly, the
correlation between CpG density and methylation was not
found to be consistent across the genome, with a positive
correlation observed in CGS of all tissue types. This result
is surprising, as it suggests the relationship between CpG
density and methylation is dependent on genomic context,
and can vary within relatively small regions, as CGIs and
CGS are directly adjacent to one another throughout the
genome. However, as the CGS tested for correlations
between CpG density and methylation had on average a
lower CpG density than CGIs and TSS tested (6.3 CpG
sites/100 bp compared to 18.7 and 17.4, respectively), it is
possible that the negative correlation between CpG dens-
ity and methylation is only observable when including
regions above a given CpG density threshold.
In addition, this study also reports a positive correl-
ation between TSS CpG density and expression apparent
for all eight tissues. While core sets of genes were
expressed at similar levels in all tissues, these genes
represented a relatively low percentage found at each
expression level. Therefore it was surprising that this
pattern was apparent in all tissues. Cytosines in CpG
compared to non-CpG context mutate at a higher rate,
with transition mutations being more common than trans-
versions due to the deamination of 5-methylcytosine to
thymidine [53, 62], resulting in the conversion of CpG to
TpG sites. Therefore, this paper proposes that the reduced
number of CpG sites at TSS of lowly expressed genes is
due to the high CpG site mutation rate in these regions
over time, predominantly due to the deamination of 5-
methylcytosine to thymidine. This theory is supported by
the observed negative correlation between TSS TpG dens-
ity and gene expression, and the weaker negative correl-
ation between TSS ApG density and gene expression.
Combined with the known alteration of methylation pat-
terns in relation to environmental stimuli, this mechanism
provides a way in which CpG methylation could result in
more permanent changes to lower gene expression.
Genetic variation plays a major role in adaptive evolution,
as demonstrated by the rapid evolution of highly expressed
genes in the brains of dogs linked to the evolution of dog-
specific characteristics [83]. In addition to changes in nu-
cleotide sequence, many studies have found gene expres-
sion differences in multiple brain regions associated with
tameness and other domestication-based phenotypes be-
tween domesticated and wild species [83–85]. Gene expres-
sion changes like these are seen in many species adapting
to a variety of environmental changes [86, 87]; however, the
mechanisms by which these changes occur are not fully
understood. While genetic variation at transcription-factor
binding sites are associated with regulatory changes and
phenotypic variation in many species [87], alternative
mechanisms, like the proposed mutation of CpG sites
at TSS, may also be responsible for long and short
term regulation of genes in response to environmental
changes. This would make DNA methylation import-
ant for adaptive evolution, as it is believed that regu-
latory changes in gene expression play a particularly
important role in the evolutionary process [3, 4].
Conclusions
This study confirmed the presence of porcine CpG
methylation patterns similar to those previously demon-
strated for humans and mice, as well as confirmed the
functional aspects of porcine CpG methylation, observ-
ing a negative correlation with gene expression at TSS
and a positive correlation within gene bodies. Additionally,
a positive correlation between TSS CpG density and gene
expression was observed in all tissue types. This suggests
that increased mutation rates at CpG sites play a signifi-
cant role in adaptive evolution by reducing CpG density at
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TSS over time, resulting in higher methylation levels in
these regions and more permanent changes to lower gene
expression. Our data support that this occurs predomin-
antly through deamination of methylated cytosine to thy-
midine, resulting in the replacement of CpG with TpG
sites in these regions, as indicated by the increased TSS
TpG density observed in non-expressed genes, resulting
in a negative correlation between expression and TSS
TpG density. Further studies are required to investigate
the similarities in methylation levels between humans and
pigs for specific genomic regions known to affect disease
progression, the differences observed in intron and exon
methylation patterns between pig tissues and human cell
lines, and the proposed adaptive evolutionary role of CpG
methylation. In conclusion, porcine CpG methylation
levels were similar to those reported for other mammals,
further supporting pigs as viable models for studying the
relationship between DNA methylation and environmen-
tal insults, as well as the diagnosis, detection, and treat-
ment of human diseases with known links to aberrant
DNA methylation patterns.
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